Filing metadata

Accession number
0001209191-23-002628
Form type
Form 3
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Jan 09, 2023
Reporting period
Jan 01, 2023
Description
Initial ownership

Explore SEC Filings Hub

3 | SEC Filings Hub